Understanding the role of inheritance in Parkinson’s disease is a major priority for many families. While the majority of cases occur without a clear family history, a significant minority of individuals carry genetic markers that increase their susceptibility or directly cause the condition. The question of whether Parkinson’s can be passed from parent to child is complex, as it involves a distinction between carrying a risk gene and developing the actual disease. Modern research has identified several key genes that help explain why the condition appears in certain families, providing a clearer picture of the risk for the next generation.
What we will discuss in this article
- The distinction between familial and sporadic Parkinson’s disease
- The probability of a child inheriting the condition from an affected parent
- Major gene mutations including LRRK2, SNCA, and GBA
- Autosomal dominant versus autosomal recessive inheritance patterns
- The concept of penetrance and why some gene carriers never get sick
- The role of early onset Parkinson’s in identifying genetic links
- Emergency guidance for identifying acute neurological changes
Familial versus sporadic Parkinson’s
In clinical practice, we categorize Parkinson’s into two main types based on whether there is a clear inheritance pattern.
Sporadic Parkinson’s is the most common form, accounting for approximately 85 to 90 percent of all cases. In these instances, there is no obvious family history, and the disease is thought to result from a complicated mix of age, environmental exposures, and many small genetic variations. Familial Parkinson’s, on the other hand, makes up about 10 to 15 percent of cases. This is where the condition appears to run in the family, often because of specific, identifiable gene mutations that are passed from parents to their children.
Probability of inheritance
For most people with a parent who has Parkinson’s, the risk of developing the condition themselves is slightly higher than the general population but remains relatively low.
In the general public, the lifetime risk of being diagnosed with Parkinson’s is approximately 1 to 2 percent. If you have a first degree relative with the condition, such as a mother or father, your risk increases to roughly 3 to 5 percent. While this is a doubling of the risk, it still means there is a 95 percent or higher chance that you will not develop the disease. However, these numbers can change significantly if a specific, rare gene mutation is known to be present in the family.
Key genes and inheritance patterns
The way Parkinson’s is passed down depends entirely on which gene is involved. The two primary patterns are autosomal dominant and autosomal recessive.
Autosomal dominant genes
In this pattern, you only need to inherit one copy of the mutated gene from one parent to have an increased risk.
- LRRK2: This is the most common genetic cause of late onset Parkinson’s. Many people with this mutation have a clinical experience very similar to the sporadic form.
- SNCA: This was the first gene identified in Parkinson’s. Mutations or multiplications of this gene can lead to the overproduction of alpha synuclein protein, often causing symptoms earlier in life.
Autosomal recessive genes
These mutations require you to inherit two copies of the faulty gene, one from each parent. The parents themselves often do not show any symptoms.
- PRKN: This is a frequent cause of early onset Parkinson’s, often appearing before the age of 40.
- PINK1 and DJ-1: These rare mutations also lead to early onset forms of the disease.
The GBA risk factor
The GBA gene is a unique case. It does not directly cause Parkinson’s in the traditional sense, but carrying a mutation in this gene is the most common genetic risk factor worldwide. It is associated with an earlier onset and a higher risk of cognitive changes, but the majority of GBA carriers never develop the condition.
Understanding penetrance
One of the most important concepts for families to understand is penetrance. This refers to the likelihood that a person who carries a specific gene will actually develop the symptoms of the disease.
Even with strong mutations like LRRK2 G2019S, the penetrance is not 100 percent. For example, a person with this mutation may have a 70 percent chance of developing Parkinson’s by the age of 80. This means that 30 percent of people with the gene will live their entire lives without ever experiencing tremors or stiffness. This suggests that other factors, such as lifestyle or protective genes, may prevent the mutation from causing harm.
Comparison of genetic and sporadic Parkinson’s
| Feature | Sporadic Parkinson’s | Familial (Genetic) Parkinson’s |
| Frequency | 85 to 90 percent of cases | 10 to 15 percent of cases |
| Age of Onset | Typically over 60 | Can be earlier (under 40 or 50) |
| Family History | Usually none | Often one or more relatives affected |
| Cause | Environment + Age + Genes | Specific gene mutation |
| Progression | Gradual | Can vary (Recessive types often slower) |
Emergency guidance
While genetic concerns are focused on the long term, sudden and severe neurological changes require immediate assessment regardless of your family history.
If you experience sudden and severe neurological changes, call 999 immediately.
Seek urgent medical help if you notice:
- A sudden total inability to move or a severe freezing episode
- Rapid onset of confusion, delirium, or distressing hallucinations
- Signs of a stroke such as facial drooping or weakness on one side
- A severe fall that results in a head injury or inability to stand
- Acute difficulty swallowing or a sudden change in breathing
To summarise
Parkinson’s disease can be passed down from parents, but this only occurs in a minority of cases. For the general population, having a parent with the condition increases the risk only slightly. True hereditary Parkinson’s involves specific mutations in genes like LRRK2 or SNCA (dominant) and PRKN or PINK1 (recessive). However, even when a gene is inherited, it is not a guarantee that the disease will develop. Factors like penetrance and environmental triggers play a major role. For those with a strong family history or a young onset diagnosis, genetic counselling can provide personalized clarity on these risks.
Should I get genetic testing if my parent has Parkinson’s?
This is a personal decision. For most people, testing is only recommended if the parent had an early onset or if multiple relatives are affected. Testing does not currently change the treatment plan but can help with family planning or research participation.
If I have the LRRK2 gene, will my children definitely get it?
No. If the mutation is autosomal dominant, each child has a 50 percent chance of inheriting the gene. Even if they inherit it, they may never develop the symptoms of the disease.
Is early onset Parkinson’s always genetic?
It is more likely to have a genetic link than late onset disease, but it is not always the case. Some early cases are still considered sporadic.
Can a mother or father pass it down more easily?
Generally, there is no significant difference between maternal or paternal inheritance for the main Parkinson’s genes. However, some researchers are looking into mitochondrial DNA, which is only passed from mothers.
Does a family history of tremors mean I will get Parkinson’s?
Not necessarily. Many people have a family history of Essential Tremor, which is a different condition and does not lead to Parkinson’s.
Can I do anything to prevent the gene from activating?
While we cannot change our genes, evidence suggests that regular exercise, a Mediterranean diet, and avoiding head injuries can support brain health and potentially delay symptom onset.
Why did I get Parkinson’s if no one else in my family has it?
The majority of cases are sporadic, meaning they occur due to a combination of age, environmental triggers, and common genetic variations that are not specifically inherited from a parent.
Authority Snapshot
This article was reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and postgraduate certifications including Basic Life Support, Advanced Cardiac Life Support, and the UK Medical Licensing Assessment. He has hands on experience in general medicine, surgery, and emergency care. Dr. Petrov has worked in hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient focused health content and teaching clinical skills to junior doctors.
